Published On: Wed, Feb 5th, 2014

Stocks Reacts on Results – General Growth Properties (NYSE:GGP), HCA Holdings (NYSE:HCA), Hologic (NASDAQ:HOLX)

General Growth Properties Inc (NYSE:GGP) [Trend Analysis] reported that its fourth-quarter profit increased as it released a higher mall-leased percentage and a better than projected increase in revenue. The upgrading in the quarterly FFO per share was mostly aided by improved than anticipated revenue growth, increase in similar store net operating income (NOI) and surge in initial rental rates. On base of short look, shares of increased 1.16% to the trading at $20.03. The firm shares is rising its 52-week low with 9.60% and behind from its 52-week high price with -12.49%.

The average revenue estimates of analysts for the quarter have 622.20 million, as compare to experts predict 613.19 million revenues for the upcoming quarter. Currently in a group of street analysts, 10 analysts rates its stocks at “Hold,” 4 analysts rate it at “strong buy” and 6 rate it a “Buy.”

Moving Forces Behind (NYSE:GGP) On Confident Run! Click Here

HCA Holdings Inc (NYSE:HCA) [Trend Analysis] hits intraday high level of $50.57, while after all it boosted 0.12% or -$0.06 to close stocks trading at $48.52 in latest trading session. The firm reported that its Q4 earnings moved up 35% on enhanced revenue that masked a drop in the hospital operator’s similar-facility admissions. The firm anticipated earnings for 2014 that were below estimates.

The recommendation trend from street professionals are, stock rated at “buy” by 14 analysts, while 9 analyst rates as a “strong buy” security. While the noticeable thing is mean recommendation of this week that stands at 1.7, [(Strong Buy 1.0 - 5.0 (Sell)] as on contradiction to last week recommendation of 1.7, which denotes zero variation in recommendations.

Why (NYSE:HCA) Rallied in Active Trading, Find here

Hologic, Inc. (NASDAQ:HOLX)  [Trend Analysis] decreased -1.76%, closing the day at $20.11 in last regular trading. The firm has market capitalization of $5.51 billion. The firm reported to a fiscal Q1 loss as revenue undermined, driven by refuses in its diagnostics segment, although adjusted earnings and revenue beat prospects. The first conference call with analysts since flattering CEO of Hologic, Stephen MacMillan declared that while the firm might sell off several of its smaller parts, he anticipates no major changes to their corporate structure. It has PEG Ratio (5 yr expected) of 1.54, along the price over sales value of $2.26 for the most recent quarter.

Why Like Investors Show Confidence on (NASDAQ:HOLX)

Disclaimer

This content does not and shall not represent an offer to sell or the solicitation of an offer to buy any of the company’s stocks or securities. As well nor shall there be any sale of the company’s securities in any state or jurisdiction in which such offer, solicitation or sale would be illegal prior to registration or qualification under the securities laws of any such state or jurisdiction. Read Full Disclaimer Here

COMPLIANCE PROCEDURE: This article is authored by outsource team “One-ten Media” on a best effort bases. The outsourced research and written content reviewed by Chartered Financial Analysts, according to the ‘Procedures Outlined’ by One-Ten Media. One-Ten Media official agree if any dispute open against its article, eMarketsdaily.com will delete its content on his platform. Open dispute Here

Offer: Teams and individuals are always welcome for their publications and contributions for eMmarketsdaily.com

Public Companies who wish to see similar coverage on their company, for consideration send us a full investors’ package to support@one-tenmedia.com.

The eMarkets Daily news department is not involved in the creation of this content.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>